2022 annual financial data
Cytek Biosciences 2022 Operating margin
Cytek Biosciences 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1.1%.
Operating income was -1,804,000 USD and net income was 2,576,000 USD.
Operating cash flow was -12,231,000 USD.
Get free Cytek Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 164,036,000 USD
- Operating income
- -1,804,000 USD
- Net income
- 2,576,000 USD
- Operating cash flow
- -12,231,000 USD